Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Boston Scientific Corp (BSX)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Boston Scientific Corp.
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 885725.
Total stock buying since 2015: $9,656,193.
Total stock sales since 2015: $529,079,619.
Total stock option exercises since 2015: $72,235,199.
Table 3. Detailed insider trading at Boston Scientific Corp (BSX) , Part 5
Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
2020-12-01 | Ralls-morrison Desiree (SVP, GC and Corp Secretary) | Option Ex | 11,472 | .00 | 0 |
2020-12-01 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Sale | 46,584 | 33.53 | 1,562,101 |
2020-12-01 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 46,584 | 7.16 | 333,541 |
2020-11-09 | Pierce David A (EVP Pres MedSurg) | Sale | 2,028 | 39.00 | 79,092 |
2020-11-03 | Mahoney Michael F (Chairman, President & CEO) | Sale | 259,207 | 35.06 | 9,087,279 |
2020-10-01 | Pierce David A (EVP Pres MedSurg) | Sale | 2,282 | 38.56 | 87,993 |
2020-09-11 | Fitzgerald Joseph Michael (EVP & Pres, Interven Cardio) | Sale | 77,640 | 40.76 | 3,164,684 |
2020-09-11 | Fitzgerald Joseph Michael (EVP & Pres, Interven Cardio) | Option Ex | 77,640 | 7.16 | 555,902 |
2020-09-03 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Sale | 9,139 | 42.31 | 386,671 |
2020-09-01 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Sale | 60,000 | 40.93 | 2,456,040 |
2020-09-01 | Mirviss Jeffrey B. (EVP&Pres, Periph Intervent) | Option Ex | 60,000 | 6.31 | 378,600 |
2020-09-01 | Pierce David A (EVP Pres MedSurg) | Sale | 2,044 | 40.70 | 83,190 |
2020-08-28 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Sale | 38,000 | 40.45 | 1,537,176 |
2020-08-28 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 6,851 | 17.26 | 118,248 |
2020-08-26 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Sale | 7,500 | 39.06 | 292,972 |
2020-08-20 | Ralls-morrison Desiree (SVP, GC and Corp Secretary) | Sale | 1,182 | 39.00 | 46,098 |
2020-08-03 | Pierce David A (EVP Pres MedSurg) | Sale | 2,385 | 38.69 | 92,275 |
2020-07-22 | Pierce David A (EVP Pres MedSurg) | Sale | 2,170 | 38.00 | 82,460 |
2020-07-01 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 854 | .00 | 0 |
2020-07-01 | Monson Jonathan (VP, Corp Controller and CAO) | Option Ex | 728 | .00 | 0 |
2020-06-03 | Pierce David A (EVP Pres MedSurg) | Sale | 1,624 | 38.00 | 61,712 |
2020-06-01 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 1,761 | .00 | 0 |
2020-06-01 | Pierce David A (EVP Pres MedSurg) | Sale | 1,969 | 38.00 | 74,822 |
2020-06-01 | Pierce David A (EVP Pres MedSurg) | Option Ex | 2,972 | .00 | 0 |
2020-05-08 | Pierce David A (EVP Pres MedSurg) | Sale | 2,057 | 38.00 | 78,166 |
2020-05-01 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 2,061 | .00 | 0 |
2020-04-17 | Pierce David A (EVP Pres MedSurg) | Sale | 14,793 | 38.00 | 562,134 |
2020-03-04 | Ballinger Kevin J. (EVP & Pres, Interven Cardio) | Sale | 1,796 | 38.05 | 68,337 |
2020-03-03 | Ballinger Kevin J. (EVP & Pres, Interven Cardio) | Option Ex | 3,303 | .00 | 0 |
2020-03-03 | Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt) | Option Ex | 3,603 | .00 | 0 |
2020-03-02 | Mackey Edward F (EVP, Operations) | Option Ex | 19,227 | .00 | 0 |
2020-03-02 | Ballinger Kevin J. (EVP & Pres, Interven Cardio) | Sale | 15,783 | 37.21 | 587,222 |
2020-03-02 | Pierce David A (EVP Pres MedSurg) | Sale | 3,485 | 38.00 | 132,430 |
2020-03-02 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Sale | 16,763 | 37.47 | 628,176 |
2020-03-02 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 9,623 | 16.31 | 156,951 |
2020-02-28 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 1,018 | .00 | 0 |
2020-02-28 | Monson Jonathan (VP, Corp Controller and CAO) | Option Ex | 815 | .00 | 0 |
2020-02-28 | Eddy Jodi Euerle (SVP and CIO) | Option Ex | 1,426 | .00 | 0 |
2020-02-28 | Meredith Ian T (EVP Global Chief Med Officer) | Option Ex | 1,018 | .00 | 0 |
2020-02-28 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 1,527 | .00 | 0 |
2020-02-28 | Mackey Edward F (EVP, Operations) | Option Ex | 2,444 | .00 | 0 |
2020-02-28 | Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr) | Option Ex | 1,833 | .00 | 0 |
2020-02-28 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 1,222 | .00 | 0 |
2020-02-28 | Brennan Daniel J. (EVP and CFO) | Option Ex | 4,481 | .00 | 0 |
2020-02-28 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Option Ex | 2,037 | .00 | 0 |
2020-02-28 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 1,629 | .00 | 0 |
2020-02-28 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 18,330 | .00 | 0 |
2020-02-28 | Pierce David A (EVP Pres MedSurg) | Option Ex | 2,444 | .00 | 0 |
2020-02-28 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 1,629 | .00 | 0 |
2020-02-25 | Ballinger Kevin J. (EVP & Pres, Interven Cardio) | Sale | 5,658 | 41.15 | 232,826 |
2020-02-25 | Pierce David A (EVP Pres MedSurg) | Sale | 4,122 | 41.15 | 169,620 |
2020-02-23 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 1,227 | .00 | 0 |
2020-02-23 | Eddy Jodi Euerle (SVP and CIO) | Option Ex | 1,104 | .00 | 0 |
2020-02-23 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 1,073 | .00 | 0 |
2020-02-23 | Mackey Edward F (EVP, Operations) | Option Ex | 2,300 | .00 | 0 |
2020-02-23 | Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr) | Option Ex | 920 | .00 | 0 |
2020-02-23 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 1,533 | .00 | 0 |
2020-02-23 | Brennan Daniel J. (EVP and CFO) | Option Ex | 5,365 | .00 | 0 |
2020-02-23 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Option Ex | 2,146 | .00 | 0 |
2020-02-23 | Ballinger Kevin J. (EVP & Pres, Interven Cardio) | Option Ex | 3,679 | .00 | 0 |
2020-02-23 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 23,759 | .00 | 0 |
2020-02-23 | Pierce David A (EVP Pres MedSurg) | Option Ex | 2,453 | .00 | 0 |
2020-02-23 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 1,840 | .00 | 0 |
2020-02-23 | Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt) | Option Ex | 4,139 | .00 | 0 |
2020-02-22 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 1,159 | .00 | 0 |
2020-02-22 | Monson Jonathan (VP, Corp Controller and CAO) | Option Ex | 1,159 | .00 | 0 |
2020-02-22 | Eddy Jodi Euerle (SVP and CIO) | Option Ex | 1,738 | .00 | 0 |
2020-02-22 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 1,014 | .00 | 0 |
2020-02-22 | Mackey Edward F (EVP, Operations) | Option Ex | 2,897 | .00 | 0 |
2020-02-22 | Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr) | Option Ex | 2,028 | .00 | 0 |
2020-02-22 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 1,593 | .00 | 0 |
2020-02-22 | Brennan Daniel J. (EVP and CFO) | Option Ex | 5,794 | .00 | 0 |
2020-02-22 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Option Ex | 2,318 | .00 | 0 |
2020-02-22 | Ballinger Kevin J. (EVP & Pres, Interven Cardio) | Option Ex | 3,766 | .00 | 0 |
2020-02-22 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 23,175 | .00 | 0 |
2020-02-22 | Pierce David A (EVP Pres MedSurg) | Option Ex | 2,607 | .00 | 0 |
2020-02-22 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 1,883 | .00 | 0 |
2020-02-22 | Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt) | Option Ex | 4,056 | .00 | 0 |
2020-02-21 | Scanlon Meghan (SVP,Pres,Urology Pelvic Health) | Option Ex | 778 | .00 | 0 |
2020-02-21 | Monson Jonathan (VP, Corp Controller and CAO) | Option Ex | 623 | .00 | 0 |
2020-02-21 | Eddy Jodi Euerle (SVP and CIO) | Option Ex | 934 | .00 | 0 |
2020-02-21 | Ralls-morrison Desiree (SVP, GC and Corp Secretary) | Option Ex | 1,324 | .00 | 0 |
2020-02-21 | Meredith Ian T (EVP Global Chief Med Officer) | Option Ex | 1,012 | .00 | 0 |
2020-02-21 | Butcher Arthur C (EVP&Pres, Asia Pacific) | Option Ex | 1,713 | .00 | 0 |
2020-02-21 | Mackey Edward F (EVP, Operations) | Option Ex | 2,726 | .00 | 0 |
2020-02-21 | Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr) | Option Ex | 1,713 | .00 | 0 |
2020-02-21 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 1,090 | .00 | 0 |
2020-02-21 | Brennan Daniel J. (EVP and CFO) | Option Ex | 3,660 | .00 | 0 |
2020-02-21 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Option Ex | 2,804 | .00 | 0 |
2020-02-21 | Ballinger Kevin J. (EVP & Pres, Interven Cardio) | Option Ex | 2,959 | .00 | 0 |
2020-02-21 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 16,824 | .00 | 0 |
2020-02-21 | Pierce David A (EVP Pres MedSurg) | Option Ex | 2,492 | .00 | 0 |
2020-02-21 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 1,713 | .00 | 0 |
2020-02-21 | Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt) | Option Ex | 3,894 | .00 | 0 |
2020-02-19 | Ballinger Kevin J. (EVP & Pres, Interven Cardio) | Sale | 1,757 | 42.31 | 74,338 |
2020-02-19 | Pierce David A (EVP Pres MedSurg) | Sale | 1,511 | 42.31 | 63,930 |
2020-02-15 | Monson Jonathan (VP, Corp Controller and CAO) | Option Ex | 738 | .00 | 0 |
2020-02-15 | Eddy Jodi Euerle (SVP and CIO) | Option Ex | 923 | .00 | 0 |
2020-02-15 | Wang Xin Warren (SVP and Pres, Asia Pacific) | Option Ex | 1,384 | .00 | 0 |
2020-02-15 | Ralls-morrison Desiree (SVP, GC and Corp Secretary) | Option Ex | 1,107 | .00 | 0 |
2020-02-15 | Meredith Ian T (EVP Global Chief Med Officer) | Option Ex | 1,107 | .00 | 0 |
2020-02-15 | Butcher Arthur C (SVP&Pres, Endoscopy) | Option Ex | 1,845 | .00 | 0 |
2020-02-15 | Mackey Edward F (EVP, Operations) | Option Ex | 2,768 | .00 | 0 |
2020-02-15 | Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr) | Option Ex | 1,845 | .00 | 0 |
2020-02-15 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 1,199 | .00 | 0 |
2020-02-15 | Brennan Daniel J. (EVP and CFO) | Option Ex | 4,153 | .00 | 0 |
2020-02-15 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Option Ex | 2,030 | .00 | 0 |
2020-02-15 | Ballinger Kevin J. (EVP & Pres, Interven Cardio) | Option Ex | 3,230 | .00 | 0 |
2020-02-15 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 1,661 | .00 | 0 |
2020-02-15 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 18,457 | .00 | 0 |
2020-02-15 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 2,768 | .00 | 0 |
2020-02-15 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 1,661 | .00 | 0 |
2020-02-15 | Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt) | Option Ex | 4,614 | .00 | 0 |
2020-02-13 | Brennan Daniel J. (EVP and CFO) | Sale | 20,463 | 42.03 | 860,039 |
2020-02-13 | Brennan Daniel J. (EVP and CFO) | Option Ex | 20,463 | 7.41 | 151,630 |
2020-02-10 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Sale | 7,500 | 42.48 | 318,630 |
2020-02-03 | Pierce David A (EVP,Pres MedSurg) | Sale | 2,150 | 42.17 | 90,665 |
2020-02-03 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Sale | 9,623 | 42.17 | 405,801 |
2020-02-03 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 9,623 | 16.31 | 156,951 |
2020-02-01 | Meredith Ian T (EVP Global Chief Med Officer) | Option Ex | 3,130 | .00 | 0 |
2020-01-17 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Sale | 23,077 | 44.00 | 1,015,388 |
2020-01-17 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Option Ex | 23,077 | 7.41 | 171,000 |
2020-01-03 | Ballinger Kevin J. (EVP & Pres, Interven Cardio) | Sale | 11,036 | 44.52 | 491,322 |
2020-01-03 | Pierce David A (EVP,Pres MedSurg) | Sale | 8,270 | 44.73 | 369,941 |
2020-01-03 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Sale | 5,025 | 44.73 | 224,758 |
2020-01-02 | Ralls-morrison Desiree (SVP, GC and Corp Secretary) | Sale | 4,050 | 45.50 | 184,275 |
2020-01-02 | Pierce David A (EVP,Pres MedSurg) | Sale | 2,152 | 45.50 | 97,916 |
2020-01-02 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Sale | 9,623 | 45.33 | 436,210 |
2020-01-02 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 9,623 | 14.70 | 141,409 |
2020-01-01 | Meredith Ian T (EVP Global Chief Med Officer) | Option Ex | 4,969 | .00 | 0 |
2020-01-01 | Butcher Arthur C (SVP&Pres, Endoscopy) | Option Ex | 7,454 | .00 | 0 |
2020-01-01 | Mackey Edward F (EVP, Operations) | Option Ex | 11,926 | .00 | 0 |
2020-01-01 | Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr) | Option Ex | 8,944 | .00 | 0 |
2020-01-01 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 5,962 | .00 | 0 |
2020-01-01 | Brennan Daniel J. (EVP and CFO) | Option Ex | 21,865 | .00 | 0 |
2020-01-01 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Option Ex | 9,939 | .00 | 0 |
2020-01-01 | Ballinger Kevin J. (EVP & Pres, Interven Cardio) | Option Ex | 16,117 | .00 | 0 |
2020-01-01 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 7,950 | .00 | 0 |
2020-01-01 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 89,449 | .00 | 0 |
2020-01-01 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 11,926 | .00 | 0 |
2020-01-01 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 7,950 | .00 | 0 |
2020-01-01 | Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt) | Option Ex | 17,582 | .00 | 0 |
2019-12-13 | Carruthers Wendy (SVP, Human Resources) | Sale | 24,220 | 45.03 | 1,090,675 |
2019-12-13 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 24,220 | 7.39 | 178,985 |
2019-12-13 | Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt) | Sale | 107,692 | 45.00 | 4,846,140 |
2019-12-13 | Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt) | Option Ex | 107,692 | 7.41 | 797,997 |
2019-12-04 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Sale | 9,623 | 42.89 | 412,711 |
2019-12-04 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 9,623 | 13.08 | 125,868 |
2019-12-03 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Option Ex | 649 | .00 | 0 |
2019-12-02 | Pierce David A (EVP,Pres MedSurg) | Sale | 5,000 | 43.33 | 216,650 |
Insider trading activities including stock purchases, stock sales, and option exercises
of BSX listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Boston Scientific Corp (symbol BSX,
CIK number 885725) see
the Securities and Exchange Commission (SEC) website.